MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension

He, Yang-Zhi-Ge; Wang, Yi-Xuan; Ma, Jing-Si; Li, Ruo-Nan; Wang, Jia; Lian, Tian-Yu; Zhou, Yu-Ping; Yang, Hao-Pu; Sun, Kai; Jing, Zhi-Cheng

doi:10.1016/j.vph.2023.107216

Vascular Pharmacology

2023

DOI: 10.1016/j.vph.2023.107216

|View full text |Cite

MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension

Yang-Zhi-Ge He,

Yi-Xuan Wang,

Jing-Si Ma

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 126 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Disease mechanisms and therapeutic targets in pulmonary hypertension: Key insights from the special issue of vascular pharmacology on pulmonary hypertension

Wojciak-Stothard,

Gupte,

Bossone

2024

Vascular Pharmacology

View full text Add to dashboard Cite

Disease mechanisms and therapeutic targets in pulmonary hypertension: Key insights from the special issue of vascular pharmacology on pulmonary hypertension

Wojciak-Stothard,

Gupte,

Bossone

2024

Vascular Pharmacology

View full text Add to dashboard Cite

MicroRNA-98: the multifaceted regulator in human cancer progression and therapy

Hazari,

Samali,

Izadpanahi

et al. 2024

Cancer Cell Int

View full text Add to dashboard Cite

MicroRNA-98 (miR-98) stands as an important molecule in the intricate landscape of oncology. As a subset of microRNAs, these small non-coding RNAs have accompanied a new era in cancer research, underpinning their significant roles in tumorigenesis, metastasis, and therapeutic interventions. This review provides a comprehensive insight into the biogenesis, molecular properties, and physiological undertakings of miR-98, highlighting its double-edged role in cancer progression—acting both as a tumor promoter and suppressor. Intriguingly, miR-98 has profound implications for various aspects of cancer progression, modulating key cellular functions, including proliferation, apoptosis, and the cell cycle. Given its expression patterns, the potential of miR-98 as a diagnostic and prognostic biomarker, especially in liquid biopsies and tumor tissues, is explored, emphasizing the hurdles in translating these findings clinically. The review concludes by evaluating therapeutic avenues to modulate miR-98 expression, addressing the challenges in therapy resistance, and assessing the efficacy of miR-98 interventions. In conclusion, while miR-98’s involvement in cancer showcases promising diagnostic and therapeutic avenues, future research should pivot towards understanding its role in tumor-stroma interactions, immune modulation, and metabolic regulation, thereby unlocking novel strategies for cancer management. Graphical Abstract

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension

Cited by 2 publications

References 126 publications

Disease mechanisms and therapeutic targets in pulmonary hypertension: Key insights from the special issue of vascular pharmacology on pulmonary hypertension

Disease mechanisms and therapeutic targets in pulmonary hypertension: Key insights from the special issue of vascular pharmacology on pulmonary hypertension

MicroRNA-98: the multifaceted regulator in human cancer progression and therapy

Contact Info

Product

Resources

About